doi: 10.1016/s0886-3350(99)00352-1 125 ShahGDVasavadaARPraveenMRShahARTrivediRH
Clinical and Research Safety Data Personal Peptide Safety: CJC-1295 without DAC has been studied in clinical trials and shows good tolerability with minimal adverse effects at research doses, no major effects on cortisol or prolactin, good safety profile across dose ranges, and no serious adverse events in research studies
However, a systematic review, obtained analyzing 52 clinical trials, on the inflammatory markers related to the consumption of dairy products, underlined their prevalent anti-inflammatory activity [151], particularly evident for fermented products
WTW is tracking over 40 weight loss vendor programs marketing to employers
A: As an experimental compound, side effects are documented within clinical trial reports